相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau
Kenneth Hensley et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
Carla Abdelnour et al.
MOVEMENT DISORDERS (2016)
Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
Abid Oueslati
JOURNAL OF PARKINSONS DISEASE (2016)
Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia
Julie Vallortigara et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Amyloid biomarkers in Alzheimer's disease
Kai Blennow et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
David R. Howlett et al.
BRAIN PATHOLOGY (2015)
Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain
Nastasia K. H. Lim et al.
HUMAN MOLECULAR GENETICS (2014)
Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease
Marta Swirski et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Amelioration of β-amyloid-induced cognitive dysfunction and hippocampal axon degeneration by curcumin is associated with suppression of CRMP-2 hyperphosphorylation
Yunliang Wang et al.
NEUROSCIENCE LETTERS (2013)
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation
Steven Petratos et al.
BRAIN (2012)
α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease
Joseph G. Quinn et al.
BRAIN RESEARCH (2012)
Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2
Joel M. Brittain et al.
FEBS LETTERS (2012)
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice
Markus Britschgi et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Brain amyloid and cognition in Lewy body diseases
Stephen N. Gomperts et al.
MOVEMENT DISORDERS (2012)
alpha 2-chimaerin controls neuronal migration and functioning of the cerebral cortex through CRMP-2
Jacque P. K. Ip et al.
NATURE NEUROSCIENCE (2012)
Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders
Rajesh Khanna et al.
FUTURE NEUROLOGY (2012)
Neuropathology underlying clinical variability in patients with synucleinopathies
Glenda M. Halliday et al.
ACTA NEUROPATHOLOGICA (2011)
Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease
Nur-Ezan Mohamed et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Human TUBB3 Mutations Perturb Microtubule Dynamics, Kinesin Interactions, and Axon Guidance
Max A. Tischfield et al.
CELL (2010)
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
Irina Kuperstein et al.
EMBO JOURNAL (2010)
Collapsin Response Mediator Protein-2 (Crmp2) Regulates Trafficking by Linking Endocytic Regulatory Proteins to Dynein Motors
Juliati Rahajeng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Protein Phosphatase 2A Facilitates Axonogenesis by Dephosphorylating CRMP2
Ling-Qiang Zhu et al.
JOURNAL OF NEUROSCIENCE (2010)
Guidance Molecules in Synapse Formation and Plasticity
Kang Shen et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity
Dag Aarsland et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)
An Atypical Role for Collapsin Response Mediator Protein 2 (CRMP-2) in Neurotransmitter Release via Interaction with Presynaptic Voltage-gated Calcium Channels
Joel M. Brittain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
EVOLUTION OF Aβ42 AND Aβ40 LEVELS AND Aβ42/Aβ40 RATIO IN PLASMA DURING PROGRESSION OF ALZHEIMER'S DISEASE: A MULTICENTER ASSESSMENT
K. Blennow et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Microtubule assembly, organization and dynamics in axons and dendrites
Cecilia Conde et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
P. Edison et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression
Adam R. Cole et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
DLB and PDD boundary issues - Diagnosis, treatment, molecular pathology, and biomarkers
C. F. Lippa et al.
NEUROLOGY (2007)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β
T Li et al.
BIOCHEMISTRY (2006)
Cyclin-dependent kinase 5, Munc18A and Munc18-interacting protein 1/x11 alpha protein up-regulation in Alzheimer's disease
EH Jacobs et al.
NEUROSCIENCE (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
A systematic review of prevalence and incidence studies of dementia with Lewy bodies
J Zaccai et al.
AGE AND AGEING (2005)
CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1 complex and axon formation
Y Kawano et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Dementia with Lewy bodies and Parkinson's disease with dementia: Are they different?
Y Tsuboi et al.
PARKINSONISM & RELATED DISORDERS (2005)
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease
GB Stokin et al.
SCIENCE (2005)
Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2:: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease
Y Uchida et al.
GENES TO CELLS (2005)
GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity
T Yoshimura et al.
CELL (2005)
Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?
D Aarsland et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2004)
Distribution of GAP-43, β-III tubulin and F-actin in developing and regenerating axons and their growth cones in vitro, following neurotrophin treatment
O Avwenagha et al.
JOURNAL OF NEUROCYTOLOGY (2003)
CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth
T Nishimura et al.
NATURE CELL BIOLOGY (2003)
Collapsin response mediator proteins (CRMPs) - Involvement in nervoust system development and adult neurodegenerative disorders
E Charrier et al.
MOLECULAR NEUROBIOLOGY (2003)
Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies
O Katsuse et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Deletion of cytosolic phospholipase A2 promotes striated muscle growth
S Haq et al.
NATURE MEDICINE (2003)
Specific compositions of amyloid-β peptides as the determinant of toxic β-aggregation
Y Yoshiike et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Microscopic analysis of polymerization dynamics with individual actin filaments
I Fujiwara et al.
NATURE CELL BIOLOGY (2002)
The GSK3β signaling cascade and neurodegenerative disease
MD Kaytor et al.
CURRENT OPINION IN NEUROBIOLOGY (2002)
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
JC Augustinack et al.
ACTA NEUROPATHOLOGICA (2002)
The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis
P Kerokoski et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains
S Taniguchi et al.
FEBS LETTERS (2001)
Accelerated Publication - Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules
YJ Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
